The study investigating the immuno-pathogenesis in myasthenia gravis using peripheral blood and resected thymus tissue

Observational study for the immunopathogenesis in myasthenia gravis using peripheral blood and resected thymus tissue - The study for investigating the pathogenesis of myasthenia gravis using peripheral blood and thymus tissue

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000045475

Enrollment

100

Registered

2021-09-14

Start date

2021-09-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myasthenia gravis

Interventions

Blood sampling for healthy control Blood sampling for myasthenia gravis

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with myasthenia gravis, neuro-immunological disorders, non-inflammatory neurological disorders, who present in Chiba University Hospital. Healthy volunteers recruited from staffs of the hospital.

Exclusion criteria

Exclusion criteria: Those who disagree with the content of the study For healthy volunteers, those who have some neurological disorders or medical diseases with potential neurological complication

Design outcomes

Primary

Measure	Time frame
Distribution of immuno-related cells from peripheral blood or thymus, Cytokine production pattern, Serum immuno-related protein levels such as cytokine	—

Countries

Japan

Contacts

Public ContactYuta Kojima

Graduate School of Medicine, Chiba University Department of Neurology

ytkjm@koto.kpu-m.ac.jp043-226-2129

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026